AARTI DRUGS
|
AARTI DRUGS Last 5 Year Income Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹2,716 Cr | ₹2,489 Cr | ₹2,155 Cr | ₹1,806 Cr | ₹1,561 Cr |
Sales | ₹2,706 Cr | ₹2,489 Cr | ₹2,155 Cr | ₹1,806 Cr | ₹1,561 Cr |
Job Work/ Contract Receipts | - | - | - | - | - |
Processing Charges / Service Income | - | - | - | - | - |
Revenue from property development | - | - | - | - | - |
Other Operational Income | ₹10 Cr | - | - | - | - |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹2,716 Cr | ₹2,489 Cr | ₹2,155 Cr | ₹1,806 Cr | ₹1,561 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹-1.76 Cr | ₹-86 Cr | ₹-12 Cr | ₹-51 Cr | ₹17 Cr |
Raw Material Consumed | ₹1,815 Cr | ₹1,701 Cr | ₹1,275 Cr | ₹1,179 Cr | ₹997 Cr |
Opening Raw Materials | ₹222 Cr | ₹199 Cr | ₹122 Cr | ₹94 Cr | ₹108 Cr |
Purchases Raw Materials | ₹1,669 Cr | ₹1,614 Cr | ₹1,241 Cr | ₹1,118 Cr | ₹939 Cr |
Closing Raw Materials | ₹197 Cr | ₹222 Cr | ₹199 Cr | ₹122 Cr | ₹94 Cr |
Other Direct Purchases / Brought in cost | ₹121 Cr | ₹109 Cr | ₹111 Cr | ₹88 Cr | ₹44 Cr |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹156 Cr | ₹128 Cr | ₹98 Cr | ₹104 Cr | ₹84 Cr |
Electricity & Power | ₹153 Cr | ₹126 Cr | ₹96 Cr | ₹102 Cr | ₹83 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | ₹3.12 Cr | ₹2.62 Cr | ₹2.65 Cr | ₹2.11 Cr | ₹1.49 Cr |
Employee Cost | ₹80 Cr | ₹69 Cr | ₹66 Cr | ₹61 Cr | ₹55 Cr |
Salaries, Wages & Bonus | ₹77 Cr | ₹66 Cr | ₹62 Cr | ₹57 Cr | ₹51 Cr |
Contributions to EPF & Pension Funds | ₹2.31 Cr | ₹2.38 Cr | ₹2.17 Cr | ₹2.25 Cr | ₹2.05 Cr |
Workmen and Staff Welfare Expenses | ₹1.50 Cr | ₹1.36 Cr | ₹1.33 Cr | ₹1.77 Cr | ₹1.63 Cr |
Other Employees Cost | - | - | - | - | - |
Other Manufacturing Expenses | ₹242 Cr | ₹231 Cr | ₹181 Cr | ₹160 Cr | ₹143 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | ₹76 Cr | ₹79 Cr | ₹67 Cr | ₹60 Cr | ₹52 Cr |
Repairs and Maintenance | ₹21 Cr | ₹13 Cr | ₹10 Cr | ₹8.24 Cr | ₹5.86 Cr |
Packing Material Consumed | ₹48 Cr | ₹49 Cr | ₹36 Cr | ₹32 Cr | ₹30 Cr |
Other Mfg Exp | ₹96 Cr | ₹89 Cr | ₹68 Cr | ₹60 Cr | ₹55 Cr |
General and Administration Expenses | ₹29 Cr | ₹30 Cr | ₹29 Cr | ₹21 Cr | ₹14 Cr |
Rent , Rates & Taxes | - | - | - | - | - |
Insurance | ₹7.68 Cr | ₹7.88 Cr | ₹7.04 Cr | ₹6.83 Cr | ₹2.95 Cr |
Printing and stationery | ₹0.20 Cr | ₹0.16 Cr | ₹0.09 Cr | ₹0.29 Cr | ₹0.21 Cr |
Professional and legal fees | ₹5.66 Cr | ₹6.34 Cr | ₹5.55 Cr | ₹3.82 Cr | ₹2.32 Cr |
Traveling and conveyance | ₹2.02 Cr | ₹1.36 Cr | ₹0.71 Cr | ₹1.22 Cr | ₹1.03 Cr |
Other Administration | ₹13 Cr | ₹15 Cr | ₹16 Cr | ₹9.23 Cr | ₹7.73 Cr |
Selling and Distribution Expenses | ₹76 Cr | ₹74 Cr | ₹71 Cr | ₹59 Cr | ₹38 Cr |
Advertisement & Sales Promotion | ₹1.17 Cr | ₹1.35 Cr | ₹0.98 Cr | ₹1.55 Cr | ₹1.90 Cr |
Sales Commissions & Incentives | ₹19 Cr | ₹15 Cr | ₹23 Cr | ₹25 Cr | ₹10 Cr |
Freight and Forwarding | ₹46 Cr | ₹51 Cr | ₹40 Cr | ₹27 Cr | ₹20 Cr |
Handling and Clearing Charges | ₹5.58 Cr | ₹5.49 Cr | ₹5.93 Cr | ₹4.80 Cr | ₹4.34 Cr |
Other Selling Expenses | ₹3.80 Cr | ₹2.02 Cr | ₹1.41 Cr | ₹0.91 Cr | ₹1.67 Cr |
Miscellaneous Expenses | ₹11 Cr | ₹8.95 Cr | ₹5.54 Cr | ₹6.88 Cr | ₹3.11 Cr |
Bad debts /advances written off | ₹1.53 Cr | ₹1.69 Cr | ₹0.85 Cr | ₹3.85 Cr | ₹0.25 Cr |
Provision for doubtful debts | - | - | - | - | - |
Losson disposal of fixed assets(net) | - | - | - | - | - |
Losson foreign exchange fluctuations | - | - | - | - | - |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹9.08 Cr | ₹7.26 Cr | ₹4.70 Cr | ₹3.03 Cr | ₹2.86 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹2,407 Cr | ₹2,156 Cr | ₹1,714 Cr | ₹1,541 Cr | ₹1,350 Cr |
Operating Profit (Excl OI) | ₹309 Cr | ₹333 Cr | ₹440 Cr | ₹266 Cr | ₹211 Cr |
Other Income | ₹2.19 Cr | ₹11 Cr | ₹4.53 Cr | ₹1.48 Cr | ₹2.41 Cr |
Interest Received | ₹0.70 Cr | ₹0.72 Cr | ₹2.60 Cr | ₹1.13 Cr | ₹1.16 Cr |
Dividend Received | ₹0.00 Cr | ₹1.60 Cr | ₹1.02 Cr | ₹0.00 Cr | ₹0.00 Cr |
Profit on sale of Fixed Assets | - | - | - | - | - |
Profits on sale of Investments | - | - | - | - | - |
Provision Written Back | - | - | - | - | - |
Foreign Exchange Gains | - | - | - | - | - |
Others | ₹1.49 Cr | ₹9.00 Cr | ₹0.91 Cr | ₹0.35 Cr | ₹1.25 Cr |
Operating Profit | ₹312 Cr | ₹344 Cr | ₹445 Cr | ₹267 Cr | ₹213 Cr |
Interest | ₹37 Cr | ₹24 Cr | ₹26 Cr | ₹37 Cr | ₹44 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | ₹9.93 Cr | ₹12 Cr | ₹17 Cr | ₹19 Cr | ₹20 Cr |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | ₹3.85 Cr | ₹3.16 Cr | ₹3.27 Cr | ₹3.70 Cr | ₹3.55 Cr |
Other Interest | ₹23 Cr | ₹9.05 Cr | ₹6.44 Cr | ₹15 Cr | ₹20 Cr |
PBDT | ₹275 Cr | ₹320 Cr | ₹419 Cr | ₹230 Cr | ₹170 Cr |
Depreciation | ₹50 Cr | ₹50 Cr | ₹50 Cr | ₹49 Cr | ₹43 Cr |
Profit Before Taxation & Exceptional Items | ₹224 Cr | ₹270 Cr | ₹369 Cr | ₹181 Cr | ₹127 Cr |
Exceptional Income / Expenses | - | - | ₹0.23 Cr | ₹4.47 Cr | ₹3.77 Cr |
Profit Before Tax | ₹224 Cr | ₹270 Cr | ₹369 Cr | ₹185 Cr | ₹131 Cr |
Provision for Tax | ₹58 Cr | ₹65 Cr | ₹89 Cr | ₹44 Cr | ₹41 Cr |
Current Income Tax | ₹59 Cr | ₹70 Cr | ₹93 Cr | ₹46 Cr | ₹34 Cr |
Deferred Tax | ₹-1.04 Cr | ₹-4.78 Cr | ₹-4.46 Cr | ₹-9.45 Cr | ₹8.71 Cr |
Other taxes | - | - | ₹0.08 Cr | ₹7.30 Cr | ₹-1.16 Cr |
Profit After Tax | ₹166 Cr | ₹205 Cr | ₹280 Cr | ₹141 Cr | ₹90 Cr |
Extra items | - | - | - | - | - |
Minority Interest | ₹-0.05 Cr | ₹0.04 Cr | ₹0.02 Cr | ₹0.00 Cr | - |
Share of Associate | - | - | - | - | - |
Other Consolidated Items | - | - | - | - | - |
Consolidated Net Profit | ₹166 Cr | ₹205 Cr | ₹280 Cr | ₹141 Cr | ₹90 Cr |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹879 Cr | ₹754 Cr | ₹592 Cr | ₹496 Cr | ₹417 Cr |
Appropriations | ₹1,045 Cr | ₹959 Cr | ₹872 Cr | ₹637 Cr | ₹507 Cr |
General Reserves | ₹15 Cr | ₹20 Cr | ₹26 Cr | ₹14 Cr | ₹8.70 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | - | - |
Other Appropriation | ₹-0.02 Cr | ₹51 Cr | ₹69 Cr | ₹27 Cr | ₹2.72 Cr |
Equity Dividend % | ₹10.00 | ₹10.00 | ₹25.00 | ₹20.00 | ₹10.00 |
Earnings Per Share | ₹17.96 | ₹22.14 | ₹30.09 | ₹60.69 | ₹38.06 |
Adjusted EPS | ₹17.96 | ₹22.14 | ₹30.09 | ₹15.17 | ₹9.51 |
Compare Income Statement of peers of AARTI DRUGS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AARTI DRUGS | ₹4,129.5 Cr | 8.8% | 3.8% | -14.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹441,838.0 Cr | 1% | 0.7% | 47.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,107.0 Cr | -1.1% | -5.8% | 61.7% | Stock Analytics | |
CIPLA | ₹120,270.0 Cr | 0.3% | -1.8% | 19.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,077.0 Cr | 6% | 11.8% | 20.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,553.2 Cr | -1.5% | -0.1% | 47% | Stock Analytics |
AARTI DRUGS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AARTI DRUGS | 8.8% |
3.8% |
-14.5% |
SENSEX | -2.1% |
-2% |
11.3% |
You may also like the below Video Courses